Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


15.10.2018

1 AJR Am J Roentgenol
1 Am J Gastroenterol
4 Anticancer Res
3 Biochem Biophys Res Commun
4 BMC Gastroenterol
1 Dig Dis Sci
1 Eur Radiol
2 Gastroenterology
22 Hepatology
1 Int J Cancer
1 J Gastroenterol
1 J Gastroenterol Hepatol
8 J Hepatol
1 N Engl J Med
1 Oncogene
1 Proc Natl Acad Sci U S A
1 Radiology
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LAWRENCE EM, Pooler BD, Pickhardt PJ
    Opportunistic Screening for Hereditary Hemochromatosis With Unenhanced CT: Determination of an Optimal Liver Attenuation Threshold.
    AJR Am J Roentgenol. 2018 Oct 9:1-6. doi: 10.2214/AJR.18.19690.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. AGARWAL PD, Lucey MR
    Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward.
    Am J Gastroenterol. 2018 Oct 5. pii: 10.1038/s41395-018-0260.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. THANGARAJAH F, Vogel C, Pahmeyer C, Eichler C, et al
    Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
    Anticancer Res. 2018;38:6023-6026.
    PubMed     Text format     Abstract available

  4. SUGIYAMA K, Narita Y, Mitani S, Honda K, et al
    Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer.
    Anticancer Res. 2018;38:5859-5866.
    PubMed     Text format     Abstract available

  5. TAKAMORI S, Takada K, Toyokawa G, Azuma K, et al
    PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:5897-5901.
    PubMed     Text format     Abstract available

  6. COLLOT T, Fumet JD, Klopfenstein Q, Vincent J, et al
    Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors.
    Anticancer Res. 2018;38:5963-5968.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  7. GAO X, Cen L, Li F, Wen R, et al
    Oral administration of indole substituted dipyrido[2,3-d]pyrimidine derivative exhibits anti-tumor activity via inhibiting AKT and ERK1/2 on hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2018 Oct 4. pii: S0006-291X(18)32053.
    PubMed     Text format     Abstract available

  8. JI DG, Guan LY, Luo X, Ma F, et al
    Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKalpha/NF-kappaB pathway.
    Biochem Biophys Res Commun. 2018;501:33-40.
    PubMed     Text format     Abstract available

  9. WANG B, Zhou TY, Nie CH, Wan DL, et al
    Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer.
    Biochem Biophys Res Commun. 2018;499:156-163.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  10. YUAN X, Chen J, Cheng Q, Zhao Y, et al
    Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery.
    BMC Gastroenterol. 2018;18:147.
    PubMed     Text format     Abstract available

  11. PARDHE BD, Shakya S, Bhetwal A, Mathias J, et al
    Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    BMC Gastroenterol. 2018;18:109.
    PubMed     Text format     Abstract available

  12. KUHN T, Nonnenmacher T, Sookthai D, Schubel R, et al
    Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults.
    BMC Gastroenterol. 2018;18:113.
    PubMed     Text format     Abstract available

  13. XIE W, Wang Q, Gao Y, Pan CQ, et al
    Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    BMC Gastroenterol. 2018;18:142.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  14. CHO SY, Kim S, Son MJ, Rou WS, et al
    Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Oct 4. pii: 10.1007/s10620-018-5307.
    PubMed     Text format     Abstract available


    Eur Radiol

  15. AMADORI M, Barone D, Scarpi E, Oboldi D, et al
    Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
    Eur Radiol. 2018;28:2969-2978.
    PubMed     Text format     Abstract available


    Gastroenterology

  16. MEHAL WZ
    Acetyl-Coenzyme A carboxylase inhibition in Nonalcoholic Steatohepatitis: Delivering as Anticipated.
    Gastroenterology. 2018 Oct 8. pii: S0016-5085(18)35103.
    PubMed     Text format    

  17. GRETEN TF, Lai CW, Li G, Staveley-O'Carroll KF, et al
    Targeted and Immune-based Therapies for Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 1. pii: S0016-5085(18)35082.
    PubMed     Text format     Abstract available


    Hepatology

  18. LIASKOU E, Hirschfield GM
    Genetic association studies and the risk factors for developing the 'immuno-bile-logic' disease PBC.
    Hepatology. 2017 Oct 24. doi: 10.1002/hep.29603.
    PubMed     Text format    

  19. LIU R, Li X, Huang Z, Zhao D, et al
    CHOP-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury.
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29540.
    PubMed     Text format     Abstract available

  20. ERICE O, Munoz-Garrido P, Vaquero J, Perugorria MJ, et al
    MiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.
    Hepatology. 2017 Sep 18. doi: 10.1002/hep.29533.
    PubMed     Text format     Abstract available

  21. PFEIFFENBERGER J, Beinhardt S, Gotthardt DN, Haag N, et al
    Pregnancy in Wilson's disease: Management and outcome.
    Hepatology. 2018;67:1261-1269.
    PubMed     Text format     Abstract available

  22. KO E, Seo HW, Jung ES, Ju S, et al
    PI3Kdelta is a new therapeutic target in hepatocellular carcinoma.
    Hepatology. 2018 Oct 9. doi: 10.1002/hep.30307.
    PubMed     Text format     Abstract available

  23. PERUGORRIA MJ, Olaizola P, Banales JM
    Cholangiocyte-to-Hepatocyte Differentiation: a Context Dependent Process and an Opportunity for Regenerative Medicine.
    Hepatology. 2018 Oct 8. doi: 10.1002/hep.30305.
    PubMed     Text format     Abstract available

  24. NARDELLI S, Gioia S, Ridola L, Farcomeni A, et al
    Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2018 Oct 5. doi: 10.1002/hep.30304.
    PubMed     Text format     Abstract available

  25. LAI SW
    Proton pump inhibitors use and risk of hepatocellular carcinoma.
    Hepatology. 2018 Oct 5. doi: 10.1002/hep.30302.
    PubMed     Text format     Abstract available


  26. Hepatology Highlights.
    Hepatology. 2018;68:1213-1216.
    PubMed     Text format    

  27. BLANER WS
    Hepatic Stellate Cells (HSCs) and Retinoids: Towards A Much More Defined Relationship.
    Hepatology. 2018 Oct 4. doi: 10.1002/hep.30293.
    PubMed     Text format     Abstract available

  28. JANSEN PLM
    Hydrodynamics of bile flow Lessons from computational modelling.
    Hepatology. 2017 Oct 27. doi: 10.1002/hep.29618.
    PubMed     Text format    

  29. STRAVITZ RT, Gottfried M, Durkalski V, Fontana RJ, et al
    Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
    Hepatology. 2018;67:1003-1013.
    PubMed     Text format     Abstract available

  30. HUO TI, Hsu CY, Liu PH
    Magic mirror on the wall: Which is the best biomarker for hepatocellular carcinoma?
    Hepatology. 2018;67:2482-2483.
    PubMed     Text format    

  31. DEAR JW
    New biomarkers for drug-induced liver injury.
    Hepatology. 2018;67:2480-2481.
    PubMed     Text format    

  32. ZHANG C, Song F
    Knockout of ULK1/2 protects against acetaminophen-induced acute liver injury independent of autophagy?
    Hepatology. 2018;67:2476-2477.
    PubMed     Text format    

  33. LAI S, Iwakiri Y
    Is miR-21 a potent target for liver fibrosis?
    Hepatology. 2018;67:2082-2084.
    PubMed     Text format    

  34. BAJAJ JS, Hylemon PB
    Gut-Liver Axis Alterations in Alcoholic Liver Disease: Are Bile Acids the Answer?
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29760.
    PubMed     Text format    

  35. BELLENTANI S, Bedogni G, Tiribelli C
    Two drinks per day does not take your fatty liver away.
    Hepatology. 2018;67:2072-2073.
    PubMed     Text format    

  36. ZHAO Q, Tang X, Wu J
    The association between nonalcoholic fatty liver disease and metabolic comorbidities.
    Hepatology. 2018;67:2474.
    PubMed     Text format    

  37. STARLINGER P, Pereyra D, Haegele S, Braeuer P, et al
    Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection.
    Hepatology. 2018;67:1516-1530.
    PubMed     Text format     Abstract available

  38. WOO BAIDAL JA, Cheng ER, Rifas-Shiman SL, Oken E, et al
    Association of vitamin E intake at early childhood with alanine aminotransferase levels at mid-childhood.
    Hepatology. 2018;67:1339-1347.
    PubMed     Text format     Abstract available

  39. ELLIS JL, Bove KE, Schuetz EG, Leino D, et al
    Zebrafish abcb11b mutant reveals novel strategies to restore bile excretion impaired by bile salt export pump deficiency.
    Hepatology. 2017 Nov 1. doi: 10.1002/hep.29632.
    PubMed     Text format     Abstract available


    Int J Cancer

  40. YANG J, Trepo E, Nahon P, Cao Q, et al
    PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
    Int J Cancer. 2018 Oct 5. doi: 10.1002/ijc.31910.
    PubMed     Text format     Abstract available


    J Gastroenterol

  41. PARK HE, Lee H, Choi SY, Kwak MS, et al
    Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter.
    J Gastroenterol. 2018 Oct 4. pii: 10.1007/s00535-018-1516.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  42. COOL J, Rosenblatt R, Kumar S, Lucero C, et al
    PORTAL VEIN THROMBOSIS PREVALENCE AND ASSOCIATED MORTALITY IN CIRRHOSIS IN A NATIONALLY REPRESENTATIVE INPATIENT COHORT.
    J Gastroenterol Hepatol. 2018 Oct 11. doi: 10.1111/jgh.14501.
    PubMed     Text format     Abstract available


    J Hepatol

  43. CRUZ-LEMINI M, Altamirano J, Ndugga N, Abraldes JG, et al
    Reply to: Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide: methodological issues of confounding and prediction models.
    J Hepatol. 2016 Dec 30. pii: S0168-8278(16)30756.
    PubMed     Text format    

  44. SAGGI H, Maitra D, Jiang A, Zhang R, et al
    Loss of hepatocyte beta-Catenin protects mice from experimental porphyria-associated liver injury.
    J Hepatol. 2018 Oct 1. pii: S0168-8278(18)32442.
    PubMed     Text format     Abstract available

  45. CHEN Y, Chen HN, Wang K, Zhang L, et al
    Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.
    J Hepatol. 2018 Oct 1. pii: S0168-8278(18)32441.
    PubMed     Text format     Abstract available

  46. JAYAKUMAR S, Middleton MS, Lawitz EJ, Mantry PS, et al
    Longitudinal Correlations Between MRE, MRI-PDFF, and Liver Histology in Patients with Nonalcoholic Steatohepatitis: Analysis of Data from a Phase 2 Trial of Selonsertib.
    J Hepatol. 2018 Oct 3. pii: S0168-8278(18)32443.
    PubMed     Text format     Abstract available

  47. POTZE W, Sanyal AJ, Lisman T
    How to assess hemostatic capacity in patients with cirrhosis?
    J Hepatol. 2016 Oct 18. pii: S0168-8278(16)30576.
    PubMed     Text format    

  48. WANNHOFF A, Friedrich K, Gotthardt DN
    Reduced influence of procoagulant changes on survival in patients with advanced cirrhosis.
    J Hepatol. 2016 Oct 24. pii: S0168-8278(16)30583.
    PubMed     Text format    

  49. TSAI PC, Huang CF, Yu ML
    Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: issue of tie interval between HCC treatment and antiviral therapy.
    J Hepatol. 2016 Nov 10. pii: S0168-8278(16)30646.
    PubMed     Text format    

  50. AYUBI E, Safiri S, Sani M, Khazaei S, et al
    Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide: methodological issues of confounding and prediction models.
    J Hepatol. 2016 Dec 30. pii: S0168-8278(16)30758.
    PubMed     Text format    


    N Engl J Med

  51. MAEDA O, Ando Y
    Cabozantinib in Hepatocellular Carcinoma.
    N Engl J Med. 2018;379:1384.
    PubMed     Text format    


    Oncogene

  52. DI RUOCCO F, Basso V, Rivoire M, Mehlen P, et al
    Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.
    Oncogene. 2018;37:627-637.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  53. SONNTAG R, Giebeler N, Nevzorova YA, Bangen JM, et al
    Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 2018;115:9282-9287.
    PubMed     Text format     Abstract available


    Radiology

  54. KHALAF MH, Sundaram V, AbdelRazek Mohammed MA, Shah R, et al
    A Predictive Model for Postembolization Syndrome after Transarterial Hepatic Chemoembolization of Hepatocellular Carcinoma.
    Radiology. 2018 Oct 9:180257. doi: 10.1148/radiol.2018180257.
    PubMed     Text format     Abstract available


    Transplantation

  55. RATZIU V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G, et al
    Recommendations for management and treatment of nonalcoholic steatohepatitis.
    Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002483.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: